Jump to content
RemedySpot.com

NEWS - FDA gives advice on divulging risks

Rate this topic


Guest guest

Recommended Posts

Guest guest

Wall Street Journal

MAY 27, 2009.

JENNIFER CORBETT DOOREN

FDA Gives Advice on Divulging Risks

The Food and Drug Administration issued proposed advertising

guidelines for drug and medical-device makers, with suggestions on

ways to present risk information to consumers and health-care

professionals.

The draft guidelines, posted Tuesday on the agency's Web site, aren't

binding, but they offer several ways that the industry can avoid

running afoul of its rules. The FDA said the omission or minimization

of risk information is the most frequent violation cited in dozens of

enforcement or warning letters each year.

The guidelines suggest a product that requires monthly blood tests to

check for liver damage should state that in clear language rather than

using language such as the need for " certain monitoring. "

***************************************************

Read the rest of the article here:

http://online.wsj.com/article/SB124339082067457033.html

Not an MD

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...